Widely Available in State Programs, Especially for Veterans
Post-traumatic stress disorder (PTSD) is one of the most commonly listed qualifying conditions in U.S. state medical marijuana programs, and it has a particular connection to veterans' health advocacy. New Mexico became the first state to explicitly add PTSD as a qualifying condition in 2009, and since then the large majority of states with medical cannabis programs — by most counts more than thirty — have followed, with only a small number of states not listing it explicitly. For many veterans and civilians with PTSD, this makes cannabis one of the more accessible state-legal options, even though the clinical research base looks quite different from how it does for other conditions on this list.
What the Research Actually Shows
Unlike chronic pain, where multiple systematic reviews report moderate evidence of benefit, PTSD does not currently have strong, consistent clinical trial evidence supporting cannabis as an effective treatment. One of the few randomized, placebo-controlled trials specifically designed to test smoked cannabis for PTSD was a Colorado-based study of 76 veterans, funded in part through federally approved research channels, comparing several different potencies of smoked cannabis, including a placebo group. It remains one of the only trials of its kind, and the results did not show a clear, consistent advantage for any single potency over placebo across all outcome measures — underscoring how limited the rigorous evidence base still is.
Why the VA/DoD Guidelines Recommend Against It
The 2023 VA/DoD Clinical Practice Guideline for the Management of PTSD, developed jointly by the Department of Veterans Affairs and Department of Defense, recommends against the use of cannabis or cannabinoid products for treating PTSD. This recommendation is based on the current lack of high-quality evidence for effectiveness, combined with documented risks, including the possibility that cannabis use can worsen certain PTSD symptoms over time, interfere with trauma-focused psychotherapy, and contribute to cannabis use disorder in a population that already faces elevated rates of substance use challenges.
Why PTSD Is a Qualifying Condition Anyway
The gap between limited clinical trial evidence and widespread state-level legal access exists largely because state qualifying-condition lists are set through legislation and ballot initiatives, not through the same evidence standards the FDA uses to approve a drug. Veteran advocacy groups played a significant role in pushing states to add PTSD to their programs, citing patient-reported symptom relief — particularly for sleep disturbances and nightmares — even in the absence of large randomized trials confirming those benefits.
The VA's Actual Policy
- The VA cannot prescribe, recommend, or pay for medical marijuana, because cannabis remains a Schedule I controlled substance under federal law, regardless of state legality.
- Veterans who use cannabis under a state-legal medical marijuana program are not denied VA healthcare benefits solely because of that use.
- VA providers are directed to discuss cannabis use openly with veteran patients as part of overall care, without penalizing them for disclosing it.
- Veterans can still be enrolled in state medical marijuana registries independently of their VA care.
A Closer Look at Nightmares and Sleep
One of the more specific and frequently cited pieces of research in this area is a small Canadian randomized, placebo-controlled crossover study published in 2015, which tested nabilone, a synthetic cannabinoid, for PTSD-related nightmares. That trial found a reduction in nightmare frequency and intensity among participants taking nabilone compared to placebo. It is often referenced as one of the more methodologically solid pieces of evidence in this space, but it was small, focused specifically on nightmares rather than overall PTSD symptom severity, and used a pharmaceutical cannabinoid rather than whole-plant cannabis from a dispensary. It does not, on its own, establish that dispensary cannabis products are an effective PTSD treatment.
What This Means for Patients
For someone with PTSD considering a state medical marijuana card, it is worth understanding that legal access and proven clinical effectiveness are two separate things. Some patients and clinicians report that cannabis, particularly for sleep and nightmare-related symptoms, provides noticeable relief; the VA/DoD guideline's caution reflects the fact that this has not been confirmed in rigorous trials and that there are documented risks, especially with regular, high-THC use over long periods. Established, evidence-based PTSD treatments — including trauma-focused psychotherapies such as prolonged exposure and cognitive processing therapy, along with certain medications — currently have a stronger research base than cannabis does.
Medical Disclaimer
This article is for general educational purposes only and is not medical advice. It does not diagnose, treat, or cure PTSD or any other condition, and it is not a substitute for care from a licensed physician, psychiatrist, or mental health professional experienced in trauma treatment. Veterans and civilians with PTSD should discuss all treatment options, including cannabis, with a qualified healthcare provider before making treatment decisions.